FDA Inspection 929619 — Glenmark Pharmaceuticals Limited
The FDA completed an inspection of Glenmark Pharmaceuticals Limited on May 29, 2015 in Solan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 29, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Solan (India)